Tue, September 13, 2022
Mon, September 12, 2022
Fri, September 9, 2022
Thu, September 8, 2022
Wed, September 7, 2022
Tue, September 6, 2022
Mon, September 5, 2022
Fri, September 2, 2022
Thu, September 1, 2022

Annabel Samimy Maintained (APLS) at Strong Buy with Increased Target to $65 on, Sep 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-65-on-sep-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Annabel Samimy of Stifel, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $60 to $65 on, Sep 8th, 2022.

Annabel has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 1 agrees with Annabel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $52 on, Tuesday, August 9th, 2022


These are the ratings of the 5 analyists that currently disagree with Annabel


  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, August 9th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022

Publication Contributing Sources